Accelerating development of first-in-class therapeutics for unmet medical needs
| Website | http://www.veralox.com |
| Employees | 12 (10 on RocketReach) |
| Founded | 2018 |
| Address | 4539 Metropolitan Ct, Frederick, Maryland 21704, US |
| Industry | Biotechnology Research |
| Keywords | Therapeutics, Drug Development, First In Class, Biotechnology, Pharmaceutical, Drug Discovery, Clinical Trials, Medical Research, Innovative Therapies, New Drugs, Unmet Needs, Research And Development, Biopharma, Life Sciences, Clinical Stage, Health Technology, Precision Medicine, Rare Diseases, Pipeline |
| Competitors | Thermo Fisher Scientific, Molecular Devices, Agilent Technologies, Illumina, Lonza, PerkinElmer, Inc., Merck Group, Bio-Rad Laboratories, ZEISS Group, Cytiva +42 more (view full list) |
Looking for a particular VERALOX Therapeutics employee's phone or email?
Jonathan Mow is the CEO of VERALOX Therapeutics.
10 people are employed at VERALOX Therapeutics.
VERALOX Therapeutics is based in Frederick, Maryland.